Literature DB >> 23089898

Characterization of early repolarization during ajmaline provocation and exercise tolerance testing.

Rachel Bastiaenen1, Hariharan Raju, Sanjay Sharma, Michael Papadakis, Navin Chandra, Martina Muggenthaler, Malini Govindan, Velislav N Batchvarov, Elijah R Behr.   

Abstract

BACKGROUND: Early repolarization (ER) in the inferior electrocardiogram leads is associated with idiopathic ventricular fibrillation, but the majority of subjects with ER have a benign prognosis. At present, there are no risk stratifiers for asymptomatic ER.
OBJECTIVE: To examine the response to ajmaline provocation and exercise in potentially high-risk subjects with ER and without a definitive cardiac diagnosis.
METHODS: Electrocardiographic data were reviewed for ER at baseline and during ajmaline and exercise testing in 229 potentially high-risk patients (mean age 37.7±14.9 years; 55.9% men). ER was defined as J-point elevation in ≥2 consecutive leads and stratified by type, territory, J-point height, and ST-segment morphology.
RESULTS: Baseline ER was present in 26 (11.4%; 19 men) patients. During ajmaline provocation and exercise, there were no new ER changes. ER with rapidly ascending ST-segment and lateral ER consistently diminished. There were 7 patients with persistent ER during ajmaline and/or exercise. They were all men with inferior or inferolateral ER and horizontal/descending ST segment. Those with persistent ER during exercise were more likely to have a history of unexplained syncope than those in whom ER changes diminished (P<.01). Subtle nondiagnostic structural abnormalities were demonstrated in 3 of these patients.
CONCLUSIONS: ER with horizontal/descending ST-segment morphology in the inferior or inferolateral leads that persists during exercise is more common in patients with prior unexplained syncope and may identify patients at higher risk of arrhythmic events. ER that persists during ajmaline provocation and/or exercise may reflect underlying subtle structural abnormalities and should prompt further investigation.
Copyright © 2013 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23089898     DOI: 10.1016/j.hrthm.2012.10.032

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  7 in total

1.  Sudden Unexplained Death - Treating the Family.

Authors:  Greg Mellor; Elijah R Behr
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-11-29

Review 2.  Some Controversies about Early Repolarization: The Haïssaguerre Syndrome.

Authors:  Peter Kukla; Marek Jastrzębski; Andrés Ricardo Pérez-Riera
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-03-10       Impact factor: 1.468

3.  Mechanisms Underlying Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in Experimental Models of Brugada Syndrome.

Authors:  Bence Patocskai; Namsik Yoon; Charles Antzelevitch
Journal:  JACC Clin Electrophysiol       Date:  2016-12-21

Review 4.  The Brugada Syndrome - Diagnosis, Clinical Implications and Risk Stratification.

Authors:  Velislav N Batchvarov
Journal:  Eur Cardiol       Date:  2014-12

Review 5.  Utility of the exercise electrocardiogram testing in sudden cardiac death risk stratification.

Authors:  Marwan M Refaat; Mostafa Hotait; Zian H Tseng
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-07       Impact factor: 1.468

Review 6.  Evaluation Of Patients With Early Repolarization Syndrome.

Authors:  Saagar Mahida; Frederic Sacher; Benjamin Berte; Seigo Yamashita; Han Lim; Nicolas Derval; Arnaud Denis; Ashok Shah; Sana Amraoui; Meleze Hocini; Pierre Jais; Michel Haissaguerre
Journal:  J Atr Fibrillation       Date:  2014-10-31

Review 7.  Early Repolarization Syndrome: Diagnostic and Therapeutic Approach.

Authors:  Felix Bourier; Arnaud Denis; Ghassen Cheniti; Anna Lam; Konstantinos Vlachos; Masateru Takigawa; Takeshi Kitamura; Antonio Frontera; Josselin Duchateau; Thomas Pambrun; Nicolas Klotz; Nicolas Derval; Frédéric Sacher; Pierre Jais; Michel Haissaguerre; Mélèze Hocini
Journal:  Front Cardiovasc Med       Date:  2018-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.